Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.78 | 14.34 |
| PEG Ratio (TTM) | 0.06 | 4.45 |
| P/S Ratio (TTM) | 0.56 | 1.49 |
| P/B Ratio (TTM) | 1.20 | 2.67 |
| P/FCF Ratio (TTM) | 6.50 | 12.46 |
| Price to 5YR AVG Earnings Ratio | -47.45 | -2.29 |
| Price to 5YR AVG FCF Ratio | 11.62 | 48.79 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 14.52% | 8.33% |
| ROE (TTM) | 21.96% | 20.04% |
| Net Profit Margin (TTM) | 9.71% | 11.00% |
| ROIC 5YR AVG | 18.95% | 6.11% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 63.99% | -174.15% | 398.47% |
| Revenue | 1.81% | -16.65% | -2.08% |
| Net Income | 62.88% | -175.19% | 405.48% |
| Cash Flow | 583.19% | 35.70% | 218.31% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.48 | 1.82 |
| Quick Ratio (TTM) | 1.51 | 1.31 |
| D/E Ratio (TTM) | 0.04 | 0.76 |
| Interest Coverage (TTM) | -140.00 | 12.05 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 3.22 | 2.87 |
| LTL to 5YR AVG FCF | 0.27 | 9.77 |
| Shares Outstanding Growth 5YR AVG | -0.10% | 7.00% |